Distal myopathies are a group of clinically and pathologically overlapping muscle diseases that are genetically complex and can represent a diagnostic challenge. Laing early-onset distal myopathy (MPD1) is a form of distal myopathy caused by mutations in the MYH7 gene, which encodes the beta myosin heavy chain protein expressed in type 1 skeletal muscle fibers and cardiac myocytes. Here, we present a case of genetically-confirmed MPD1 with a typical clinical presentation but distinctive light microscopic and ultrastructural findings on muscle biopsy. A 39-year-old professional male cellist presented with a bilateral foot drop that developed by age 8; analysis of the family pedigree showed an autosomal dominant pattern of inheritance. The physical exam demonstrated bilateral weakness of ankle dorsiflexors, toe extensors, and finger extensors; creatine kinase level was normal. Biopsy of the quadriceps femoris muscle showed predominance and hypotrophy of type 1 fibers; hybrid fibers with co-expression of slow and fast myosin proteins, both in highly atrophic and normal size range; moth-eaten fibers and minicores; lack of rimmed vacuoles; and rare desmin-positive eosinophilic sarcoplasmic inclusions.
Introduction
Distal myopathies are a group of muscle disorders that share a distinctive clinical presentationpreferential weakness of distal skeletal muscles -but are otherwise heterogeneous: more than 20 genetically distinct forms have been described, some presenting early in life and others in adulthood 1 . Laing early-onset distal myopathy (MPD1) is a form of autosomal dominant distal myopathy that is caused by mutations in the MYH7 gene; MYH7 encodes the beta myosin heavy chain protein, which is expressed in type 1 skeletal muscle fibers and cardiac myocytes 2 . (Two other clinical phenotypes -hypertrophic/dilated cardiomyopathy 3 and myosin storage/hyaline body myopathy 4 -can be caused by MYH7 mutations; it is thought that the disease phenotype mostly depends on the location of mutation within the myosin protein, with MPD1 mutations primarily affecting the myosin tail that is critical for coiled-coil formation and binding of the myosin-associated proteins 2 .) In the large majority of cases, MPD1 presents with early-onset ankle dorsiflexion weakness. Symptoms first appear in early childhood and may also include weakness of neck flexors and a hanging big toe; in some cases, weakness of shoulder muscles and finger extensors can occur, as well as axial weakness that can lead to scoliosis 2, 5, 6 . The disease typically progresses very slowly and the majority of patients retain ambulatory function throughout life; creatine kinase (CK) level is usually not elevated. The muscle biopsy findings are generally nonspecific, with type 1 fiber atrophy and predominance observed in the majority of described cases 6, 7 ; however, muscle morphology can vary significantly even among the members of the same family 8, 9 . Here, we present a case of genetically-confirmed MPD1 with a typical clinical presentation but distinctive light microscopic and ultrastructural findings on muscle biopsy.
Clinical Summary
A left-handed professional male cellist with a history of bilateral foot drop form early childhood presented for evaluation and genetic counseling at the age of 39. He had lost the ability to dorsiflex both feet at the age of 4-5 and had developed complete bilateral foot drop over the ensuing 2-3 years, at which point the disease appeared to stabilize with no further progression noticed subjectively. The initial diagnostic work-up, including electromyography, was performed at the age of 9 and yielded no specific diagnosis. At 39, the patient reported no complete bilateral foot drop. In the fourth generation, the proband's nephew IV-1 was asymptomatic at age 16, while the proband's nieces IV/2 (age 14) and IV/3 (age 11) showed mild motor abnormalities suspicious for MPD1 (IV/2 developed mild left foot drop by age 10, while IV/3 could not walk on heels but was otherwise able to walk normally at the time of genetic testing); the fourth generation siblings have not been evaluated by a neurologist. Per report, some of the affected individuals also developed cardiac disease ranging from a mild decrease in the cardiac ejection fraction (II/5 and III/4) to a heart failure requiring pacemaker at age 60 (II/4); however, detailed medical information was not available.
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Pathological and Genetic Findings
The patient underwent muscle biopsy from the left quadriceps femoris; the biopsy was taken preferential involvement of type 1 fibers. NADH-TR histochemistry showed a spectrum of sarcoplasmic abnormalities that ranged from a moderate degree of "moth-eateness" to welldeveloped mini-cores (Fig. 2C) . Trichrome stain showed rare eosinophilic cytoplasmic inclusions but no rimmed vacuoles (Fig. 2D ). Desmin immunoperoxidase stain demonstrated rare desmin-positive subsarcolemmal inclusions (Fig. 2E) , likely corresponding to eosinophilic inclusions seen on trichrome stain. Clefted fibers with membrane invaginations were easily identifiable on Toluidine blue-stained resin sections (Fig. 2F) . Aberrant fast myosin expression was seen in scattered type 1 fibers, some of which were highly atrophic while others had normal diameter (Fig. 3) ; sarcoplasmic inclusions were myosin-negative.
Ultrastructural analysis demonstrated focal areas of myofibrillar disorganization with granulofilamentous material and Z-band streaming (Fig. 4A) , likely corresponding to sarcoplasmic inclusions seen on trichrome and desmin stains. The most striking ultrastructural 6 feature was the presence of abnormal membrane invaginations reminiscent of myotendinous junctions (MTJs) (Figs. 4B-C) . The myofibrillar apparatus abutting sarcolemmal invaginations was disorganized and contained mitochondria with dense matrical granules and paracrystalline arrays (Fig. 4D) ; in contrast, the mitochondria away from these areas were morphologically unremarkable.
The clinical presentation and general muscle biopsy features suggested MPD1 as the most likely diagnosis; we thus performed sequencing analysis of the MYH7 gene as described previously 6 . The sequencing revealed heterozygous deletion of a GAG triplet at position 4522-4524 (Fig. 5) ; this mutation is predicted to result in the loss of a glutamate residue at position 1508 of the beta myosin heavy chain protein [c.4522_4524delGAG (p.Glu1508del)] and has already been linked to MPD1 in several unrelated families throughout the world 6, 10, 11 . The same heterozygous mutation was present in the affected family members III-4, IV-2 and IV-3, while the unaffected family member IV-1 showed a normal MYH7 genotype.
Discussion
At the time of its phenotypic and genetic characterization 2, 5 , MPD1 was thought to have a relatively stereotypic clinical presentation and disease course; in contrast, the underlying muscle pathology showed considerable heterogeneity 7 . Since then, both the clinical and pathologic spectra of MPD1 have significantly widened, with diverse muscle group involvement and varying pathology seen even in cases with the same underlying mutation 8, 9 . In the current report, we describe a patient with the clinical presentation and disease course typical for classic MPD1, but with unusual light microscopic and ultrastructural features on muscle biopsy (Figs. 2 and 4 ).
Muscle biopsies from MPD1 patients usually show type 1 fiber predominance, fiber size variation with type 1 fiber atrophy, hybrid fibers that express both slow and fast myosin proteins, and a spectrum of sarcoplasmic abnormalities that range from moth eaten fibers to welldeveloped mini-cores [6] [7] [8] [9] ; rimmed vacuoles, which are frequently seen in other distal myopathies, are usually not present 1, 7 . Less commonly, the pathologic spectrum of MPD1 includes eosinophilic inclusion bodies 12 and mitochondrial abnormalities 9, 13 . In the current case, the biopsy of a clinically less involved quadriceps muscle showed most of these features, including type 1 fiber predominance and fiber size variation (Fig. 2B) ; scattered hybrid fibers (including 7 highly atrophic hybrid fibers thought to be pathognomonic for MPD1 6 ; Fig. 3 ); mini-cores ( Fig.   2C ) and rare desmin-positive eosinophilic sarcoplasmic inclusions (Figs. 2D-E); and disorganization of the myofibrillary apparatus / granulofilamentous material (Fig. 4A) .
Interestingly, while type 1 fibers were smaller than type 2 fibers on average, they were not actually atrophic (average diameter, 53.4 µm); this may be a function of the muscle chosen for biopsy (quadriceps femoris instead of tibialis anterior), but could also reflect the fact that the proband engages in a level of physical activity that is unusually high for an MPD1 patient. In addition to these commonly observed pathologic abnormalities, the current biopsy showed frequent fibers with extensive membrane invaginations (Figs. 2A, 2B, 2F ) that on ultrastructural examination had an MTJ-like appearance (Figs. 4B-D) .
MTJs are specialized structures that allow transmission of mechanical force from muscle fiber myofilaments to tendon collagen fibers 14 . On longitudinal view, MTJ consists of numerous muscle fiber projections that are limited by sarcolemma and basement membrane; these projections interdigitate with tendon processes composed of fibroblasts, fibroblast processes, and collagen fibers 15 . On cross-sectional view of MTJ, muscle fibers appear fissured, with collagen fibers and fibroblast processes inside the clefts; sarcolemma abutting the clefts is thickened and overlies a sarcoplasmic zone with a Z-band-like electron density 15, 16 . Clefted fibers observed in the proband's biopsy showed many classic MTJ features, including fibroblast processes and collagen fibrils within clefts and Z-band-like electron dense material under the sarcolemma (Figs. 4B-D) . However, these MTJ-like structures were preferentially found in type 1 fibers (Fig.   2B ) and were randomly distributed throughout the biopsy, a pattern that would not be expected for true MTJs. Furthermore, the biopsy was taken from the central part of the vastus lateralis, away from both tendons. Finally, mitochondria adjacent to the MTJ-like sarcolemmal invaginations in the proband's biopsy showed ultrastructural abnormalities (Fig. 4D ) that have not been reported in association with true MTJs 17, 18 . Taken together, we believe that fiber clefting/fragmentation accompanied by aberrant MTJ-like structure formation in type 1 fibers is a part of the MPD1 phenotype in this patient, widening the pathologic spectrum previously associated with this disease.
Sequencing of the MYH7 gene demonstrated the presence of a heterozygous c.4522_4524delGAG (p.Glu1508del) mutation in the proband and three other affected members of his family; this mutation was previously linked to MPD1 in (i) a French family, a Norwegian 8 family, and a single Finnish patient 10 , (ii) a Belgian family 11 , and (iii) another US family 6 .
Interestingly, muscle biopsies from other patients with p.Glu1508del mutation showed no unusual morphologic features and were not described as harboring MTJ-like structures; a similar lack of correlation between genetics and muscle pathology has been observed with two other MPD1 mutations (p.K1729del 9 and p.Leu1597Arg 8 ). Interestingly, the p.Glu1508del patient cohort described to date also shows a significant clinical variability: while all patients presented with classic bilateral foot drop at an early age, the involvement of other muscle groups and the speed of disease progression were highly variable. In particular, the disease manifestations in the Belgian family 11 appear to be quite severe, while the family described in the current report manifests a very mild clinical course (for example, the proband [currently age 41] is actively involved in multiple sports and continues to play cello professionally despite the development of mild finger extensor weakness; his father (II/5), a school orchestra conductor for 40 years, continues to regularly walk, bike, and lift weights at the age of 66). These discrepancies between genotype and phenotype suggest a significant role for the genetic background / modifier genes in MPD1 pathogenesis, a feature of the disease that will need to be explored in the future studies. 
